LFB Research Grant in Immunology

LFB Research Grant in Immunology is sponsored by LFB Biopharmaceuticals. Grants supporting projects in immunodeficiencies and immune-mediated neuropathies, awarded to healthcare professionals in the UK.

Research Grant - LFB Agora LFB Research Grant in Immunology 2026 LFB's immunology research grant scheme aims to support the work of healthcare professionals in the fields of immunodeficiency and immune-mediated neuropathy. Proposals are sought for research that aims to improve the management and/or quality of life of patients treated within licensed indications of intravenous immunoglobulins.

The sixth LFB Immunology research grant awards are planned for 2026. ● ONE PROJECT IN IMMUNODEFICIENCIES FIELD ● ONE PROJECT IN THE IMMUNE-MEDIATED NEUROPATHIES FIELD The amount of each award is €20000 Healthcare Providers (HCP), non-Professor, from predefined countries can apply with a project that fulfills the aim of the program. No products nor placebo are part of the award and could not be requested as a replacement for the award.

● Increase the awareness of Immune-mediated disorders in terms of diagnosis or patient management. ● Improve the overall quality of life of patients. ● In patients treated within the licensed indications of Intravenous Immunoglobulins .

Austria, Belgium, France, Germany, Greece, Italy, Mexico, Netherlands, Spain, Turkey, UK. Projects fulfilling the eligibility criteria will be reviewed by the Grant Jury. A member of LFB's medical staff will sit on the jury as an observer and will not take part in the decision-making process.

They have won the previous editions Discover the previous winners and their awarded projects For immunodeficiency projects Prof. Javier Carbone, Sapin Prof. Francisco Espinosa, Mexico Dr. Nizar Mahlaoui, France Dr. Leif Hanitsch, Germany For immune-mediated neuropathy projects Prof. Helmar Lehmann, Germany Prof. Yesim Parman, Turkey Prof. Yusuf Rajabally, UK Prof. Shahram Attarian, Frane Prof. Steven Vargas, Mexico Opening date for applications: 01 February 2026 ● Immune-mediated neuropathies projects: 31 October 2026 ● Immunodeficiency projects: 31 October 2026 ● Download and send all the requested documents (see below) to: immunology.

grant@lfb. fr ● Feedback will be provided to applicants by mid-December 2026 ● For further information, please contact: immunology. grant@lfb.

fr The submission file ( In English ) includes: ● Identity of the participant: Please fill out the Curriculum Vitae document (2 pages maximum) ● Short description of the team ● A referencing letter from the Head of the service as a supporter of the project ● Publications list of the candidate/team related to the research ● The candidate must indicate any conflict of interest, with one of the members of the Review Committee.

Description of the project ( 5 pages maximum ): ● The rationale of the research and how it answers the chosen unmet need; ● The objective of the research and expected results; ● Nature of the work and relevance of the methodology; ● Timelines and budget, feasibility, and difficulties to foresee: the project must not exceed 18 months (beginning from the acceptance project by the committee); ● Applicant must declare any foreseen difficulties.

Would you like to receive the latest scientific updates ? The prices will be awarded at a scientific congress or meeting, for which sponsorship will also be provided by LFB. Details will be notified to the winners.

If the selected project includes any LFB IVIg product, the applicant must follow LFB pharmacovigilance procedures. A pharmacovigilance notice will be provided to the applicant to inform them of the applicable pharmacovigilance procedures.. Heathcare Professional Confidentiality (HCP)